Schedule 13G ownership disclosure
Ritter Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 767836109
Event date: 2017-09-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,900,000
- Percent of class
- 9.9400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-17-000091
- Form type
- SC 13G
- Filer
- AIxCrypto Holdings, Inc.
- CIK
- CIK 1460702
- Filed
- Oct 03, 2017
- Reporting period
- Sep 29, 2017
- Description
- Schedule 13G beneficial ownership